Roche ‘considers’ Alexion bid
July 16, 2013Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris
Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
The pharma industry in the public imagination
July 16, 2013Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma
Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …
NICE rejects Pfizer blood cancer drug
July 16, 2013Sales and Marketing BMS, CML, NICE, Pfizer, bosulif
NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …
Aesica appoints two new business development managers
July 16, 2013Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas
Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …
Irish eyes smiling as Pfizer plans $130m investment
July 15, 2013Manufacturing and Production IDA, Pfizer, cork, grange
The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …
Lilly revisits Alzheimer’s drug
July 15, 2013Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab
Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …
Roche’s Erivedge gains conditional EU approval
July 15, 2013Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf
Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …
Next generation digital firms for Europe wanted
July 15, 2013Medical Communications, Sales and Marketing J&J, JJ, digital, innovation
Digital health start-ups from across Europe are being called on to form a part of Johnson & Johnson Innovation’s inaugural …
Simon Lowth exits AstraZeneca
July 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth
AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …
FDA approves Boehringer’s lung cancer drug
July 12, 2013Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer
Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …
UK science future looking brighter – survey
July 12, 2013Research and Development, Sales and Marketing UCB, science
A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …
Eliquis poised for new US approval
July 12, 2013Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin
Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …
Eisai backs disease fund
July 12, 2013Research and Development, Sales and Marketing Eisai, Japan, TB, partnership
A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …
China accuses GSK of large scale bribery
July 12, 2013Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat
Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …
Publicis Life Brands Resolute appoints account director
July 12, 2013Medical Communications, Sales and Marketing PLBR
Publicis Life Brands Resolute (PLBR) has hired Simon Goldsborough as an account director. Goldsborough brings to the firm over 10 …
MHRA orders recall of Wockhardt drugs after import ban
July 11, 2013Manufacturing and Production MHRA, Wockhardt, recall
The UK regulatory authority has asked for a recall of medicines made at a Wockhardt facility in India, shortly after …
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
AstraZeneca shores up Cambridge move
July 11, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development
AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …
Tissue Regenix
 appoints non-executive director
July 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing tissue regenix
Regenerative medical devices firm Tissue Regenix has appointed Randeep Singh Grewal as its non-executive
 director of the Group. Grewal has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
